Primary adenocarcinoma of the lung - histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma

被引:13
|
作者
Oskarsdottir, Gudrun Nina [1 ,2 ]
Bjornsson, Johannes [3 ]
Jonsson, Steinn [1 ,2 ]
Isaksson, Helgi J. [4 ]
Gudbjartsson, Tomas [2 ,5 ]
机构
[1] Landspitali Univ Hosp, Dept Pulmonol, Reykjavik, Iceland
[2] Univ Iceland, Fac Med, Reykjavik, Iceland
[3] Akureyri Hosp, Dept Pathol, Reykjavik, Iceland
[4] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
[5] Landspitali Univ Hosp, Dept Cardiothorac Surg, Reykjavik, Iceland
关键词
Lung adenocarcinoma; histology; classification; adenocarcinoma subtypes; INTERNATIONAL-ASSOCIATION; GRADING SYSTEM; PROGNOSTIC-SIGNIFICANCE; CANCER; SURVIVAL; MUTATIONS; RECURRENCE; THERAPY; PATTERN; MARKER;
D O I
10.1111/apm.12522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenocarcinoma is the most common histological type of lung carcinoma. Recently the histologic classification of adenocarcinomas in the lung was modified to better reflect biologic properties and prognosis. We reviewed the histology of all primary lung adenocarcinomas operated on in Iceland during a 20-year period and assessed the impact of histology on survival. This nationwide study included 285 patients (mean age 67 years, 57% female), who underwent resection in Iceland from 1991 to 2010. Tumors were reclassified according to the current IASLC/ATS/ERS classification system. Overall survival was estimated by the Kaplan-Meier method and Cox regression analysis used to evaluate prognostic factors of overall mortality. Acinar predominant adenocarcinoma was the most common histological subtype (46%) followed by solid-predominant (SPA) with mucin production comprised (23%). Non-invasive carcinomas were rare. A difference in survival between the histological adenocarcinoma subtypes was not seen (p = 0.32) and multivariate analysis showed that advanced stage and age predicted worse outcome, but histologic subtyping of adenocarcinoma did not. In this nation-wide study there was not a statistical difference in survival according to adenocarcinoma subtypes and the histological subtype did not predict mortality. Preinvasive and minimally invasive adenocarcinomas were rare.
引用
收藏
页码:384 / 392
页数:9
相关论文
共 50 条
  • [21] Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons
    Nakamura, Haruhiko
    Takagi, Masayuki
    SURGERY TODAY, 2015, 45 (11) : 1341 - 1351
  • [22] Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspective
    Rocco, Raffaele
    Jones, David R.
    Morabito, Alessandro
    Franco, Renato
    La Mantia, Elvira
    Rocco, Gaetano
    JOURNAL OF THORACIC DISEASE, 2014, 6 : S547 - S551
  • [23] The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects
    Zugazagoitia, Jon
    Belen Enguita, Ana
    Antonio Nunez, Juan
    Iglesias, Lara
    Ponce, Santiago
    JOURNAL OF THORACIC DISEASE, 2014, 6 : S526 - S536
  • [24] The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management
    Tang, Yong
    He, Zhe
    Zhu, Qihang
    Qiao, Guibin
    JOURNAL OF THORACIC DISEASE, 2014, 6 : S589 - S596
  • [25] Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
    Shimada, Yoshihisa
    Saji, Hisashi
    Nomura, Masaharu
    Matsubayashi, Jun
    Yoshida, Koichi
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    ONCOTARGETS AND THERAPY, 2013, 6 : 1597 - 1604
  • [26] Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases
    Nakamura, Haruhiko
    Saji, Hisashi
    Shinmyo, Takuo
    Tagaya, Rie
    Kurimoto, Noriaki
    Koizumi, Hirotaka
    Takagi, Masayuki
    CLINICAL LUNG CANCER, 2015, 16 (03) : 209 - 215
  • [27] Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations Analysis of 440 Japanese Patients
    Yoshizawa, Akihiko
    Sumiyoshi, Shinji
    Sonobe, Makoto
    Kobayashi, Masashi
    Fujimoto, Masakazu
    Kawakami, Fumi
    Tsuruyama, Tatsuaki
    Travis, William D.
    Date, Hiroshi
    Haga, Hironori
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) : 52 - 61
  • [28] Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients
    Liu Chao
    Huang Yi-Sheng
    Chen Yu
    Yan Li-Xu
    Luo Xin-lan
    Luo Dong-Lan
    Chen Jie
    Wu Yi-Lon
    Liu Yan Hui
    LUNG CANCER, 2014, 86 (02) : 164 - 169
  • [29] Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification
    Kerr, Keith M.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (10) : 832 - 838
  • [30] CORRELATION BETWEEN EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION AND HISTOLOGIC CLASSIFICATION OF LUNG ADENOCARCINOMA ACCORDING TO THE IASLC/ATS/ERS IASLC/ATS/ERS2011
    Tinh Van Nguyen
    Chau Quy Ngo
    Hung Van Nguyen
    Doi Quang Nguyen
    RESPIROLOGY, 2019, 24 : 175 - 176